Capitalists Hate Capitalism: An Analysis of Adam Smith's Quote
Adam Smith's quote, "People of the same trade seldom meet together, even for merriment and diversion, but the conversation ends in a conspiracy against the public, or in some contrivance to raise prices," is analyzed in this blog. Learn why capitalists hate capitalism and what can be done to combat it.
Cory Doctorow @pluralistic@mamot.fr Red Team Blues
Author, journalist, activist. Touring "Red Team Blues," an anti-finance finance thriller https://t.co/fpDYDNRrr7
-
As the Marxist agitator #AdamSmith once said, "People of the same trade seldom meet together, even for merriment and diversion, but the conversation ends in a conspiracy against the public, or in some contrivance to raise prices."
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
1/ pic.twitter.com/nWYUx563Nc -
If you'd like an essay-formatted version of this thread to read or share, here's a link to it on https://t.co/iSBh8sqXw0, my surveillance-free, ad-free, tracker-free blog:https://t.co/WJnlPMXw7h
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
2/ -
Smith understood that capitalists hate capitalism. They don't want to compete with one another, because that would interfere with their ability to raise the prices their customers pay and reduce the wages they pay their workers.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
3/ -
Thus #PeterThiel's anticapitalist rallying cry, "competition is for losers," or #WarrenBuffett's extreme horniness for businesses with "wide, sustainable moats."
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
4/ -
These anti-capitalist capitalists *love* big government. They love no-bid military contracts, they love #ACA subsidies for health insurance companies, they love #FarmBill cash for #Cargill and #Monsanto. What they don't love is *markets*.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
5/ -
Case in point: #pharma giant #Merck. The #InflationReductionAct (#IRA) includes a provision that allows #Medicare to (finally) start (weakly) negotiating the prices it pays for (a tiny handful of) drugs.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
6/ -
If you're scratching your head and wondering if you understood that correctly, let me assure you, you did: the US government is currently *prohibited* from negotiating drug prices when it bargains with pharma companies.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
7/ -
In other words: Medicare simply pays a pharma companies - whose products build on billions in publicly funded basic research, whose taxes are reduced by billions in research credits, whose patents are backstopped by billions in enforcement - whatever it demands.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
8/ -
To do otherwise, you see, would be #socialism. Markets are "efficient" because they "discover prices" through bidding and selling.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
9/ -
In the case of publicly purchased drugs, the price that Uncle Sucker "discovers" is inevitably "a titanic sum" or possibly "add a couple more zeroes, wouldya?"
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
10/ -
Enter the IRA. Starting in 2026, Medicare will be permitted to negotiate the price of ten (10) drugs. The negotiations will use the prices of other drugs from the dysfunctional, monopolized market as a starting point and go up from there.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
11/ -
The negotiations go on for three years, and there are multiple stages where pharma companies can hit pause with court challenges:https://t.co/isBzytYuiB
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
12/ -
The system will *not* consider the prices #Medicaid or the #VA (which *do* bargain) pay. Nor will it consider the prices that other governments pay - the US is alone in the wealthy world in offering the anticapitalist price-taking posture when dickering with pharma.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
13/ -
But this isn't enough for Merck. They are suing the Biden administration over the IRA's drug pricing plan, arguing that it is an unconstitutional taking under the Fifth Amendment:https://t.co/uL9WyjB3H5
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
14/ -
Merck is represented by #BigLaw firm #JonesDay, who made their bones by representing the #RJReynolds from smokers with lung-cancer, arguing that the smoking/cancer link wasn't scientifically sound.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
15/ -
That's not the only fanciful argument they put before a judge: Jones Day also represented #Trump in his attempts to overturn the 2020 election (they also hired Trump's counsel #DonMcGahn as he exited the White House's revolving door).
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
16/ -
As @ryanlcooper writes for @TheProspect, Merck's argument is that the "fair market" value of its drugs can only be discovered if its single largest customer - Medicare - simply pays whatever Merck demands of it:https://t.co/JZXOXzSFgB
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
17/ -
They explicitly denounce the idea that a powerful buyer should use its market power to extract price concessions from sellers like Merck.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
18/ -
> Leveraging all federal insurance benefits (amounting to over half of the prescription drug market) to coerce companies to abandon their First and Fifth Amendment rights is a quintessential unconstitutional condition.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
19/ -
Rebutting this argument, Health Secretary #XavierBecerra said, "negotiating for the best price is as American as apple pie. Since when is competition in this American system a bad thing? Why should we be the patsies around the world and pay the highest prices for medicines?"
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
20/ -
The irony here is that Merck itself is a *very* powerful buyer. Whether negotiating commercial leases, raw materials or wages, Merck is ruthless in extracting the lowest prices it can from its suppliers.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
21/ -
The company attained its massive scale the old fashioned way: buying it. By drawing on its nearly limitless access to the capital markets, Merck bought out dozens of its competitors:https://t.co/uJESgZcIGE
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
22/ -
Anticapitalist investors funded these acquisitions in the expectation that Merck would be able to use its market dominance to pay suppliers less and charge customers more.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
23/ -
Also, Merck can use some of the resulting windfall to corrupt and bully its regulators so that it could buy still more companies, charge still higher prices, and impose crushingly low prices on still more suppliers.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
24/ -
The IRA's drug-bargaining provisions are extraordinarily weak. When they were first mooted in 2021, I talked about how Democrats were caving on muscular drug price controls that would benefit every American (except a handful of pharma shareholders):https://t.co/hDNgboHWFo
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
25/ -
They did so despite wild, bipartisan support for imposing price discipline on Big Pharma, and ending the 300% premium Americans pay for their drugs relative to their cousins abroad.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
26/ -
95% of Democrats support strong price controls; so do 82% of independents - and *71% of Republicans*:https://t.co/GPTTeJ7mNG
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
27/ -
No one believes Big Pharma's scare stories about how this would kill R&D: 93% of Americans reject this idea, including 90% of Republicans.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
28/ -
They're right - nearly all US basic pharma R&D is directly funded by the federal government, with pharma companies privatizing the gains:https://t.co/XDgbTPCE6t
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
29/ -
Despite the fact that really whipping the shit out of Big Pharma would be both popular and good for America, the Dems' final version of pharma bargaining is a barely-there nothingburger. where ten drugs will become slightly cheaper, *after* the next federal election.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
30/ -
This is called "political realism" and it's a fantasy.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
The idea that limiting drug controls to the faintest, most modest measures would make them easier to attain was obvious nonsense from the start, and Merck's anticapitalist lawsuit proves it.
31/ -
Merck will settle for nothing less than total central planning - by Merck. For Merck, the role of the federal government is to wave through a stream of mergers culminating in Merck's ownership of every major drug.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
32/ -
For Merck, the US government exists to grant patent extensions for its drugs to carry them into the 25th century and beyond, and to pay unlimited sums for these drugs through Medicare.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
33/ -
Given all that, there would have been no downside to the Dems passing an IRA that subjected the drug companies the same modest, commensense, market-based discipline we see in Canada, or the UK, or France, or Germany, or Switzerland.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
34/ -
But that's not the IRA we got. Instead of defending a big, visionary program in court, the Biden admin is facing down Jones Day and Merck to defend the most yawn-inducing, incrementalist half-measure. What a wasted opportunity.
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
35/ -
Image:
— Cory Doctorow @pluralistic@mamot.fr Red Team Blues (@doctorow) June 9, 2023
Flying Logos (modified)https://t.co/ara5oPO6cM
CC BY-SA 4.0https://t.co/zMicjQMHyT
eof/